NK042
Sponsors
Anhui Provincial Hospital, Shanghai NK Cell Technology Co., LTD
Conditions
Advanced Solid TumorsGynecologic Cancer
Phase 1
A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites
Not yet recruitingNCT06415500
Start: 2024-05-06End: 2026-12-06Target: 9Updated: 2024-05-16
A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors
RecruitingNCT06773091
Start: 2025-02-07End: 2026-12-31Target: 76Updated: 2025-02-11